Age-specific urinary metabolite signatures and functions in patients with major depressive disorder

31Citations
Citations of this article
33Readers
Mendeley users who have this article in their library.

Abstract

Major depressive disorder (MDD) patients in different age ranges might have different urinary metabolic phenotypes, because age could significantly affect the physiological and psychological status of person. Therefore, it was very important to take age into consideration when studying MDD. Here, a dual platform metabolomic approach was performed to profile urine samples from young and middle-aged MDD patients. In total, 18 and 15 differential metabolites that separately discriminated young and middle-aged MDD patients, respectively, from their respective HC were identified. Only ten metabolites were significantly disturbed in both young and middle-aged MDD patients. Meanwhile, two different biomarker panels for diagnosing young and middle-aged MDD patients, respectively, were identified. Additionally, the TCA cycle was significantly affected in both young and middle-aged MDD patients, but the Glyoxylate and dicarboxylate metabolism and phenylalanine metabolism were only significantly affected in young and middle-aged MDD patients, respectively. Our results would be helpful for developing age-specific diagnostic method for MDD and further investigating the pathogenesis of this disease.

Cite

CITATION STYLE

APA

Chen, J. J., Xie, J., Li, W. W., Bai, S. J., Wang, W., Zheng, P., & Xie, P. (2019). Age-specific urinary metabolite signatures and functions in patients with major depressive disorder. Aging, 11(17), 6626–6637. https://doi.org/10.18632/aging.102133

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free